Navigation Links
U.S. Army Awards General Dynamics Contract for Biological Detection System Production and Support

CHARLOTTE, N.C., April 7, 2008 /PRNewswire-FirstCall/ -- The U.S. Army Research, Development and Engineering Command Acquisition Center, Aberdeen Proving Ground, Md., has awarded General Dynamics Armament and Technical Products a contract option worth approximately $43 million to produce and test Joint Biological Point Detection Systems (JBPDS). The contract terms also include field-support packages and user training for the technology. This award is a modification of a 2004 contract and brings the total value to date to more than $200 million. General Dynamics Armament and Technical Products is a business unit of General Dynamics (NYSE: GD).

The JBPDS is a self-contained instrument suite that rapidly detects and identifies biological warfare agents. Available in man-portable, shelter- based, ship-based and trailer-mounted variants, the JBPDS is a Joint Services program and is configured to meet the operational requirements of the U.S. Army, Navy, Marine Corps and Air Force.

Work will be performed at General Dynamics' Charlotte, N.C., detection and protection production facility, which provides development, manufacturing and integration of advanced biological and chemical agent detection systems.

According to Bill Gural, vice president and general manager of detection systems for General Dynamics Armament and Technical Products, "The Joint Biological Point Detection System provides customers with an advanced level of protection. The system is based on a robust bio-detection instrument suite that is fully functional in any operational environment. The system provides automatic detection and identification of airborne biological agents at very low levels, triggers local and remote warning systems, and communicates threat information over standard communication systems. We're proud to be on the leading edge of innovations to protect our country from evolving threats and look forward to continuing our work with the U.S. Army Research, Development and Engineering Command Acquisition Center."

General Dynamics Armament and Technical Products, located in Charlotte, N.C., provides a broad range of system solutions for military and commercial applications. The company designs, develops and produces high-performance armament systems; defensive armor solutions; aerospace components; mobile shelter systems; and is the leading U.S. producer of biological and chemical detection systems. More information about General Dynamics Armament and Technical Products can be found on the Internet at

General Dynamics, headquartered in Falls Church, Va., employs approximately 83,500 people worldwide and reported 2007 revenues of $27.2 billion. The company is a market leader in business aviation; land and expeditionary combat systems, armaments and munitions; shipbuilding and marine systems; and information systems and technologies. More information about the company is available on the Internet at

SOURCE General Dynamics Armament and Technical Products
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Life Science Executive Exchange 2008 To Sponsor Industry Awards
2. Department of Defense Awards $5.8 Million Contract Modification Providing Additional Funding for PharmAthenes Protexia(R) Program
3. Three CEOs and University President Named Winners of Greater Baltimore Committees 2008 Baltimore Region Bioscience Awards
4. Life Science Industry Awards to Be Announced June 3, 2008 in Boston
5. Greater Baltimore Committee to Announce Winners of Third Baltimore Region Bioscience Awards at Ceremonies on March 18
6. CareEvolution and SCHIEx Named Interoperability Finalists for 2008 Microsoft Healthcare Users Group (MS-HUG) Healthcare Innovation Awards
7. New Enterprise Forum Celebrates 22nd Anniversary, Presents Annual Entrepreneur Awards to Randal Charlton & Others
8. Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants
9. The Michael J. Fox Foundation Awards $2 Million to Shed Light on Role of LRRK2 and Alpha-Synuclein Genes in Parkinsons Disease
10. GBC Seeks Nominations for Regions Third Annual Bioscience Awards
11. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
Post Your Comments:
(Date:12/1/2015)... 1, 2015 Vancouver ... lancet that features Owen Mumford,s unique Comfort Zone Technology®. ... Unistik® Touch is a touch activated lancet that features ... Owen Mumford, a leading medical device manufacturer, today unveils ... available initially in the US before expanding out to ...
(Date:12/1/2015)... Dec. 1, 2015 Today the Allen Institute ... Seattle,s South Lake Union neighborhood, the ... Mercer Street and Westlake Avenue North, the 270,000 square ... Institute for Brain Science and the Allen Institute for ... and founder of the Allen Institute. "We started by ...
(Date:12/1/2015)... CAMBRIDGE, Mass. , Dec. 1, 2015 ... and the McGovern Institute for Brain Research at MIT ... system that significantly cut down on "off-target" editing errors. ... issues in the use of genome editing. ... report that changing three of the approximately 1,400 amino ...
(Date:12/1/2015)... -- Twist Bioscience, a company focused on synthetic DNA, today announced ... selected as one of Foreign Policy,s 100 Leading ... of life . Each year, Foreign Policy selects ... have changed lives and are shaping the world. ... to be recognized among these incredible global leaders," said Leproust. ...
Breaking Biology Technology:
(Date:11/11/2015)... --  MedNet Solutions , an innovative SaaS-based eClinical technology company ... to announce that it will be a Sponsor of the ... be held November 17-19 in Hamburg , ... iMedNet , MedNet,s easy-to-use, proven and affordable ... been able to deliver time and cost savings of up ...
(Date:11/9/2015)... Nov. 09, 2015 ... of the "Global Law Enforcement Biometrics ... --> ) has announced ... Enforcement Biometrics Market 2015-2019" report to ... Markets ( ) has announced the ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):